Do Young Lim

2.6k citations

44 papers · 1.9k indexed · h-index 25

Biochemistry top 5%
Pharmacology top 2%
- Pharmacological Effects of Natural Compounds 4
Molecular Medicine top 5%
Toxicology top 5%
Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 6
- Ginseng Biological Effects and Applications 3
- Genomics, phytochemicals, and oxidative stress 3
Oncology
- Cancer-related Molecular Pathways 8
Cancer Research
- Cancer, Hypoxia, and Metabolism 4
- Cancer, Lipids, and Metabolism 4
Immunology
- interferon and immune responses 3

Co-authors: Jung Han Yoon Park Zigang Dong Ann M. Bode Jung H.Y. Park Angela L. Tyner Hanyong Chen Ki Won Lee Jae In Jung
Cited by: Biochemistry Pharmacology Molecular Medicine
Journals: Carcinogenesis (4 papers)Cancer Research (4 papers)Cancer Prevention Research (4 papers)
Partner nations: United States South Korea China

In The Last Decade

Do Young Lim

42 papers receiving 1.8k citations

Peers

Countries citing papers authored by Do Young Lim

Since Specialization

Citations

This map shows the geographic impact of Do Young Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Do Young Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Do Young Lim more than expected).

Fields of papers citing papers by Do Young Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Do Young Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Do Young Lim. The network helps show where Do Young Lim may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Do Young Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Do Young Lim Line = papers co-authored together Do Young Lim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	p21 produces a bioactive secretome that places stressed cells under immunosurveillance Science ·Ines Sturmlechner,Cheng Zhang,Miina Pruuli,阎晓霞,Karthik B. Jeganathan,Naomi Hamada,Horst Haun,David J. Friedman,Lindsley Antony,İsmail Can,Masakazu Hamada,Do Young Lim,Jeong‐Heon Lee,Tamás Ördög,Rémi-Martin Laberge,Virginia Smith Shapiro,Darren J. Baker,Hu Li,Jan M. van Deursen	2021	177
2	ARC Is a Critical Protector against Inflammatory Bowel Disease (IBD) and IBD-Associated Colorectal Tumorigenesis Cancer Research ·Qiushi Wang,Tianshun Zhang,Wang Jinsui,Do Young Lim,Keke Wang,Ruihua Bai,Ting Wang,Joohyun Ryu,Hanyong Chen,Ke Yao,Wei-Ya Ma,Lisa A. Boardman,Ann M. Bode,Zigang Dong	2020	5
3	Targeting PRPK Function Blocks Colon Cancer Metastasis Molecular Cancer Therapeutics ·Tatyana A. Zykova,Feng Zhu,Lei Wang,Haitao Li,Do Young Lim,Ke Yao,Eunmiri Roh,Sang Pil Yoon,Yuhki NAGATA,Ki Beom Bae,Weihong Wen,Seung Ho Shin,Janos Nadas,Yan Li,Weiya Ma,Ann M. Bode,Zigang Dong	2018	15
4	RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation Oncogene ·Ke Yao,Sungyoung Lee,Cong Peng,Do Young Lim,Hiroyuki Yamamoto,Joohyun Ryu,Tae‐Gyu Lim,Hanyong Chen,Guoguo Jin,Zhenjiang Zhao,A. Nart,Wei-Ya Ma,Ann M. Bode,Zigang Dong	2018	15
5	The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis EBioMedicine ·Tatyana A. Zykova,Feng Zhu,Lei Wang,Haitao Li,Ruihua Bai,Do Young Lim,Ke Yao,Ann M. Bode,Zigang Dong	2017	39
6	Curcumin Suppresses Proliferation of Colon Cancer Cells by Targeting CDK2 Cancer Prevention Research ·Tae‐Gyu Lim,Sungyoung Lee,Zunnan Huang,Do Young Lim,Hanyong Chen,Sung Keun Jung,Ann M. Bode,Ki Won Lee,Zigang Dong	2014	91
7	Caffeic Acid Directly Targets ERK1/2 to Attenuate Solar UV-Induced Skin Carcinogenesis Cancer Prevention Research ·Ge Yang,Yang Fu,Margarita Malakhova,Igor Kurinov,Feng Zhu,Ke Yao,Haitao Li,Hanyong Chen,Wěi Li,Do Young Lim,Yuqiao Sheng,Ann M. Bode,Ziming Dong,Zigang Dong	2014	47
8	(+)-2-(1-Hydroxyl-4-Oxocyclohexyl) Ethyl Caffeate Suppresses Solar UV-Induced Skin Carcinogenesis by Targeting PI3K, ERK1/2, and p38 Cancer Prevention Research ·Do Young Lim,Mee‐Hyun Lee,Seung Ho Shin,Jessica Santiago Silva,Joohyun Ryu,Lei Shan,Honglin Li,Ann M. Bode,Weidong Zhang,Zigang Dong	2014	7
9	3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer Journal of Biological Chemistry ·Yuqiao Sheng,Wěi Li,Feng Zhu,Kangdong Liu,Hanyong Chen,Ke Yao,Kanamata Reddy,Do Young Lim,Naomi Oi,Haitao Li,Cong Peng,Wei Ya,Ann M. Bode,Ziming Dong,Zigang Dong	2014	19
10	mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin Science ·Seong A. Kang,Michael E. Pacold,Christopher Cervantes,Do Young Lim,Hua Jane Lou,Kathleen Ottina,Nathanael S. Gray,Benjamin E. Turk,Michael B. Yaffe,David M. Sabatini	2013	3
11	Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K Cancer Prevention Research ·Mi-Sung Kim,Jong‐Eun Kim,Do Young Lim,Zunnan Huang,Hanyong Chen,Alyssa Langfald,Ronald A. Lubet,Clinton J. Grubbs,Zigang Dong,Ann M. Bode	2013	69
12	CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo Carcinogenesis ·Dong Joon Kim,Mee‐Hyun Lee,Kanamata Reddy,Yani Li,Do Young Lim,Hua Xie,Sungyoung Lee,Young Il Yeom,Ann M. Bode,Zigang Dong	2013	5
13	Identification of an Aurora Kinase Inhibitor Specific for the Aurora B Isoform Cancer Research ·Hua Xie,Mee‐Hyun Lee,Feng Zhu,Kanamata Reddy,Cong Peng,Yan Li,Do Young Lim,Dong Joon Kim,Xiang Li,Jane-Heloise; id_orcid 0000-0001-8566-7581 Nancarrow,Haitao Li,Weiya Ma,Ronald A. Lubet,Jian Ding,Ann M. Bode,Zigang Dong	2012	26
14	Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo Carcinogenesis ·Hua Xie,Feng Zhu,Zunnan Huang,Mong‐Hong Lee,Dukjoon Kim,Xiang Li,Do Young Lim,Qingjie Li,Sun Chul Kang,Li Huang,N. S. Reddy,Lei Wang,W Ma,Ronald A. Lubet,Ann M. Bode,Zigang Dong	2012	14
15	Hexane/ethanol extract of Glycyrrhiza uralensis and its active compound isoangustone A induce G1 cycle arrest in DU145 human prostate and 4T1 murine mammary cancer cells The Journal of Nutritional Biochemistry ·Mi Ra Seon,So Young Park,Soo Jin Kwon,Soon Sung Lim,Hyun Ju Choi,Heesook Park,Do Young Lim,Jong‐Sang Kim,Choong Hwan Lee,Jongdai Kim,Jung Han Yoon Park	2011	39
16	Induction of Cell Cycle Arrest in Prostate Cancer Cells by the Dietary Compound Isoliquiritigenin Journal of Medicinal Food ·Dai Zhen-b,Do Young Lim,Hyun Ju Choi,Jae In Jung,Won‐Yoon Chung,Jung Han Yoon Park	2009	48
17	Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity Cancer Letters ·Dai Zhen-b,Do Young Lim,Han‐Jin Cho,Mi Ra Seon,Jin‐Kyung Kim,Boo-Yong Lee,Jung Han Yoon Park	2009	48
18	Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin American Journal of Physiology-Gastrointestinal and Liver Physiology ·Do Young Lim,Miquel impresor Albert,Angela L. Tyner,Jung H.Y. Park	2006	154
19	Fisetin Inhibits the Activities of Cyclin-Dependent Kinases Leading to Cell Cycle Arrest in HT-29 Human Colon Cancer Cells Journal of Nutrition ·Xianghua Lu,Jae In Jung,Han‐Jin Cho,Do Young Lim,Hyun Sook Lee,Hyang Sook Chun,Dae Young Kwon,Jung Han Yoon Park	2005	93
20	Treatment of Recurrent Aborters by Immunization With Paternal Cells—Controlled Trial American Journal of Reproductive Immunology ·M.N. Cauchi,Do Young Lim,Erwin S. Penn,Michael Kloss,R. J. Pepperell	1991	86

About Do Young Lim

Do Young Lim is a scholar working on Cancer Research, Toxicology and Geriatrics and Gerontology, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Pharmacological Effects of Natural Compounds (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer, Lipids, and Metabolism (4 papers), interferon and immune responses (3 papers), Ginseng Biological Effects and Applications (3 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). The work is most often cited by research in Biochemistry (158 citations), Pharmacology (204 citations) and Molecular Medicine (100 citations). Do Young Lim has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Jung Han Yoon Park, Zigang Dong, Ann M. Bode, Jung H.Y. Park, Angela L. Tyner, Hanyong Chen, Ki Won Lee, Jae In Jung, Han‐Jin Cho and Hyun Ju Choi. Their work appears in journals such as Carcinogenesis, Cancer Research, Cancer Prevention Research, Molecular Carcinogenesis and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact